| http://www.w3.org/ns/prov#value | - About 5% developed resistance to tobramycin and 22%co-amoxiclav, clarithromycin or azithromycin are the most stopped treatment probably or possibly related to treatment duecommonly used long-term prophylactic agents in children. to cough, wheeze and breathlessness.452There are no long-term studies to suggest preference of one over Nebulised colistin is used in patients with bronchiectasisanother a
|
